| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/JN/129.2.399 |
| P698 | PubMed publication ID | 10024618 |
| P2093 | author name string | Y Zhang | |
| P A Murphy | |||
| S Hendrich | |||
| J E Cunnick | |||
| T T Song | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 399-405 | |
| P577 | publication date | 1999-02-01 | |
| P1433 | published in | Journal of Nutrition | Q3186931 |
| P1476 | title | Daidzein and genistein glucuronides in vitro are weakly estrogenic and activate human natural killer cells at nutritionally relevant concentrations | |
| P478 | volume | 129 |
| Q33878344 | Absorption Study of Genistein Using Solid Lipid Microparticles and Nanoparticles: Control of Oral Bioavailability by Particle Sizes |
| Q73905904 | Absorption and metabolism of genistin in the isolated rat small intestine |
| Q34840779 | Absorption and metabolism of polyphenols in the gut and impact on health. |
| Q59158089 | Absorption and pharmacokinetics of grapefruit flavanones in beagles |
| Q36177446 | Aggressive prostate cancer is prevented in ERαKO mice and stimulated in ERβKO TRAMP mice |
| Q21285066 | Antioxidant and Antityrosinase Activity of Flemingia macrophylla and Glycine tomentella Roots |
| Q33567159 | Bioavailability and pharmacokinetics of genistein: mechanistic studies on its ADME. |
| Q34881447 | Bioavailability of isoflavones. |
| Q33853845 | Bioavailability of the polyphenols: status and controversies |
| Q36296183 | Breast cancer resistance protein (ABCG2) determines distribution of genistein phase II metabolites: reevaluation of the roles of ABCG2 in the disposition of genistein |
| Q55311614 | Dietary Flavonoids in the Prevention of T2D: An Overview. |
| Q34386003 | Dietary agents in cancer prevention: flavonoids and isoflavonoids. |
| Q24631085 | Disposition of hop prenylflavonoids in human breast tissue |
| Q60934565 | Effect of Natural Compounds on NK Cell Activation |
| Q36661701 | Effect of sulphation on the oestrogen agonist activity of the phytoestrogens genistein and daidzein in MCF-7 human breast cancer cells |
| Q90219187 | Effects of dietary soy isoflavones and soy protein source on response of weanling pigs to porcine reproductive and respiratory syndrome viral infection |
| Q58726869 | Effects of isoflavones on breast tissue and the thyroid hormone system in humans: a comprehensive safety evaluation |
| Q37712718 | Endocrine Disruptors and Obesity |
| Q35119637 | Evaluation of CYP450 inhibitory effects and steady-state pharmacokinetics of genistein in combination with cholecalciferol and citrated zinc bisglycinate in postmenopausal women |
| Q36132293 | First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics |
| Q46503204 | Flavones induce immunomodulatory and anti-inflammatory effects by activating cellular anti-oxidant activity: a structure-activity relationship study |
| Q64938182 | Flavonoids: New Frontier for Immuno-Regulation and Breast Cancer Control. |
| Q28484462 | Formation of phosphoglycosides in Caenorhabditis elegans: a novel biotransformation pathway |
| Q24529917 | Goitrogenic and estrogenic activity of soy isoflavones |
| Q39402790 | High-throughput quantification of soy isoflavones in human and rodent blood using liquid chromatography with electrospray mass spectrometry and tandem mass spectrometry detection |
| Q64060517 | Identification of equol-7-glucuronide-4'-sulfate, monoglucuronides and monosulfates in human plasma of 2 equol producers after administration of by LC-ESI-MS |
| Q37697416 | Identification of glyceollin metabolites derived from conjugation with glutathione and glucuronic acid in male ZDSD rats by online liquid chromatography-electrospray ionization tandem mass spectrometry |
| Q34427368 | Immunomodulators for prevention and treatment of infectious diseases in food-producing animals |
| Q35013908 | In vivo metabolism of Talosin A, new isoflavonol glycoside from Kitasatospora kifunensis, in rats |
| Q34881523 | Inactivation of thyroid peroxidase by soy isoflavones, in vitro and in vivo |
| Q26801110 | Interaction of Isoflavones with the BCRP/ABCG2 Drug Transporter |
| Q37312570 | Isoflavone genistein protects human vascular endothelial cells against tumor necrosis factor-alpha-induced apoptosis through the p38beta mitogen-activated protein kinase |
| Q37173328 | Isoflavones and the prevention of breast and prostate cancer: new perspectives opened by nutrigenomics |
| Q59193360 | Isoflavones as functional food components |
| Q34840838 | Isoflavones for prevention of cancer, cardiovascular diseases, gynecological problems and possible immune potentiation |
| Q34460804 | Isoflavones, genistein and daidzein, regulate mucosal immune response by suppressing dendritic cell function |
| Q26155136 | NTP-CERHR expert panel report on the reproductive and developmental toxicity of genistein |
| Q42994335 | Nutrikinetic study of genistein metabolites in ovariectomized mice. |
| Q24812744 | Optimization of a yeast estrogen screen and its applicability to study the release of estrogenic isoflavones from a soygerm powder |
| Q37385369 | Pharmacokinetics and bioavailability of the isoflavone biochanin A in rats |
| Q37697453 | Pharmacokinetics of equol, a soy isoflavone metabolite, changes with the form of equol (dietary versus intestinal production) in ovariectomized rats |
| Q35893432 | Phenoxodiol, an anticancer isoflavene, induces immunomodulatory effects in vitro and in vivo |
| Q34555669 | Phytoestrogens in foods |
| Q43571871 | Placental transfer of the soy isoflavone genistein following dietary and gavage administration to Sprague Dawley rats |
| Q36470225 | Profiling the metabolome changes caused by cranberry procyanidins in plasma of female rats using (1) H NMR and UHPLC-Q-Orbitrap-HRMS global metabolomics approaches. |
| Q79102074 | Rapid Gut Transit Time and Slow Fecal Isoflavone Disappearance Phenotype Are Associated with Greater Genistein Bioavailability in Women |
| Q38000980 | Regulation of the immune response by soybean isoflavones |
| Q35888396 | Role of metabolism in the effects of genistein and its phase II conjugates on the growth of human breast cell lines |
| Q36096060 | Simultaneous determination of genistein and its four phase II metabolites in blood by a sensitive and robust UPLC-MS/MS method: Application to an oral bioavailability study of genistein in mice |
| Q35335557 | Soy isoflavone phase II metabolism differs between rodents and humans: implications for the effect on breast cancer risk |
| Q64057097 | Soy isoflavones and their metabolites modulate cytokine-induced natural killer cell function |
| Q26751544 | Soy-based renoprotection |
| Q44374144 | Structures of (-)-epicatechin glucuronide identified from plasma and urine after oral ingestion of (-)-epicatechin: differences between human and rat. |
| Q39658851 | The effects of different lignans and isoflavones, tested as aglycones and glycosides, on hormone receptor-positive and -negative breast carcinoma cells in vitro |
| Q43545533 | The impact of chronic estrogen deprivation on immunologic parameters in the ovariectomized rhesus monkey (Macaca mulatta) model of menopause |
| Q98946293 | Trifolium pratense L. (red clover) extract and doxorubicin synergistically inhibits proliferation of 4T1 breast cancer in tumor-bearing BALB/c mice through modulation of apoptosis and increase antioxidant and anti-inflammatory related pathways |
| Q50882459 | Use and validation of HT/HC assays to support 21st century toxicity evaluations. |
| Q34781792 | Use of conventional and -omics based methods for health claims of dietary antioxidants: a critical overview. |
Search more.